(Trump reversed that effort this year, barring Medicare and Medicaid from using them to treat the disease of obesity.) This plan to simplify payments and expand access would not make all drugs affordable in the United States, but increasing accessibility to GLP-1s can get us on the road to eliminating the significant problem of cardiometabolic disease and improving our health
Levodopas long-term efficacy is, on the other hand, compromised by the development of response oscillations and drug-induced dyskinesias in a majority of patients due to the progressive degeneration of dopaminergic neurons and pulsatile administration of levodopa, and these limitations are the main reasons for continued efforts towards improvements of current dopaminergic strategies
More recent controlled trials confirm it improves wrinkles, dermal density, and firmness over 12-24 weeks, with significant improvements in skin texture and firmness (particularly with the higher 0.1% concentration)
Weight Loss That Protects What Matters GLP-1 medications can be life-changing, enabling many to achieve fat loss and improved metabolic health after years of struggle